ArticleFrontiers in cardiovascular medicine2022

New adverse coronary events in valve-in-valve TAVR and native TAVR-A 2-year matched cohort.

Ofir Koren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.